Quantum Computing is trading 5.06% down at $6.53 as hotter-than-forecast September CPI and rising Treasury yields weigh on risk-sensitive technology shares.
- Reuters reported U.S. stocks lower as rate-hike expectations increased.
- On October 14, Quantum Computing announced a collaboration with INmune Bio to explore potential applications for an Alzheimer’s drug candidate, marking its first pharmaceutical and biotech commercial customer.
- The positive announcement is company news, but available reporting does not connect it to the share decline.